MedPath
PPB Approval

TEGLUTIK ORAL SUSPENSION 5MG/ML

HK-67243

Prescription only Medicines

October 27, 2021

Company Information

Company Details

1/F, BUILDING 20E, PHASE 3, HONG KONG SCIENCE PARK, SHATIN, NEW TERRITORIES

Active Ingredients

riluzole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TEGLUTIK ORAL SUSPENSION 5MG/ML - PPB 批准文号 | MedPath